Building Quality into iPSCs Early to Minimise Testing, Improve Reproducibility & Accelerate Commercialisation

• Genetically engineering iPSCs from initial development to reduce testing and enhance product consistency
• Detailing the ipsc manufacturing process for effective scale up
• Highlighting the use of allogeneic products, aiming to demonstrate their safety and efficacy

Speakers:

Damien Zanker

Head of Clinical Manufacturing

Cartherics Pty Ltd